Display options
Share it on

Clin Psychopharmacol Neurosci. 2015 Dec 31;13(3):319-20. doi: 10.9758/cpn.2015.13.3.319.

The Accompanying Changes in Brain Structure of a Remitted Depression Patient with the Bupropion Treatment.

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology

Yi-Cheng Hou, Chien-Han Lai

Affiliations

  1. Department of Nutrition, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan.
  2. Department of Psychiatry, Cheng Hsin General Hospital, Taipei City, Taiwan.
  3. Department of Biomedical Imaging and Radiological Sciences, National Yang-Ming University, Taipei City, Taiwan.

PMID: 26598593 PMCID: PMC4662168 DOI: 10.9758/cpn.2015.13.3.319

Abstract

The impacts from the bupropion on the brain structures have seldom been mentioned in the literature. The bupropion is a kind of antidepressant with dual action in the norepinephrine and dopamine receptors. Here we have a case to share about the bupropion-related effects in the brain structure.

Keywords: Brain volume; Bupropion; Gray matter volume; White matter volume

References

  1. AJNR Am J Neuroradiol. 2012 Nov;33(10):1918-24 - PubMed
  2. J Magn Reson Imaging. 2011 Aug;34(2):438-44 - PubMed
  3. Neuropsychopharmacology. 2004 Jul;29(7):1230-8 - PubMed
  4. Psychopharmacology (Berl). 2013 Oct;229(3):527-38 - PubMed
  5. Neurosci Lett. 2004 Feb 12;356(2):135-9 - PubMed
  6. CNS Neurol Disord Drug Targets. 2007 Apr;6(2):87-100 - PubMed
  7. Eur Arch Psychiatry Clin Neurosci. 2009 Nov;259 Suppl 2:S199-204 - PubMed
  8. Biol Psychiatry. 2001 Nov 15;50(10):729-42 - PubMed
  9. J Pharmacol Exp Ther. 2000 Apr;293(1):8-14 - PubMed
  10. Neuroimage. 2010 Jun;51(2):578-85 - PubMed

Publication Types